SCHEMBL8525259

SCHEMBL8525259

O=c1[nH]c(-c2ccccn2)nnc1-c1ccc2ccccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.48
NPC1 O15118 6/20 0.48
RAB9A P51151 6/20 0.48
LMNA P02545 6/20 0.48
MAPT P10636 4/20 0.48
KDM4E B2RXH2 4/20 0.48
PKM P14618 2/20 0.48
KMT2A Q03164 2/20 0.48
ALDH1A1 P00352 6/20 0.47
HTT P42858 5/20 0.47
L3MBTL1 Q9Y468 4/20 0.47
GAA P10253 1/20 0.47
HIF1A Q16665 1/20 0.47
NPSR1 Q6W5P4 2/20 0.45
TP53 P04637 1/20 0.45
TSHR P16473 1/20 0.45
KLF5 Q13887 1/20 0.45
HSD17B10 Q99714 1/20 0.45
OPRK1 P41145 1/20 0.44
PAX8 Q06710 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8525087 0.83 NPC1 (0.64) SMN1; SMN2NPC1RAB9ALMNAMAPT
SCHEMBL8524777 0.83 NPC1 (0.68) SMN1; SMN2NPC1RAB9ALMNAMAPT
SCHEMBL11288499 0.83 NPY5R (0.57) SMN1; SMN2NPC1RAB9ALMNAMAPT
SCHEMBL11137248 0.81 NPC1 (0.53) SMN1; SMN2NPC1RAB9ALMNAMAPT
SCHEMBL11135408 0.81 RAB9A (0.53) SMN1; SMN2NPC1RAB9ALMNAMAPT
SCHEMBL11135466 0.81 NPC1 (0.53) SMN1; SMN2NPC1RAB9ALMNAMAPT
SCHEMBL8524931 0.81 NPC1 (0.53) SMN1; SMN2NPC1RAB9ALMNAMAPT
SCHEMBL11140374 0.81 NPC1 (0.53) SMN1; SMN2NPC1RAB9ALMNAMAPT
SCHEMBL8525318 0.81 NPC1 (0.53) SMN1; SMN2NPC1RAB9ALMNAMAPT
SCHEMBL11131683 0.81 NPC1 (0.53) SMN1; SMN2NPC1RAB9ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999007352-A2 METHOD FOR PROMOTING EXPRESSION OF LDL RECEPTOR GENE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1999-02-18 WO claimed
EP-0030038-B1 1,2,4-TRIAZINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-10-05 EP disclosed
US-4343801-A FUNGICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1982-08-10 US disclosed
EP-0030038-A1 1,2,4-Triazine derivatives, process for their production and pharmaceutical composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-06-10 EP disclosed